Supreme Court rules in weedkiller cancer case
-
By
-
O. Rose Broderick
-
June 26, 2026
-
0 min
High Court Decision in Glyphosate-Related Cancer Litigation
Overview
The Supreme Court ruled that Bayer, the maker of Roundup, cannot face failure-to-warn lawsuits in state courts regarding cancer risks associated with glyphosate.
Background
The legal landscape surrounding glyphosate, a widely used herbicide, has been contentious, particularly regarding its potential carcinogenic effects. The International Agency for Research on Cancer (IARC) classified glyphosate as 'probably carcinogenic to humans,' while the U.S. Environmental Protection Agency (EPA) has maintained that it is 'not likely to be carcinogenic to humans.'
Data Highlights
No numerical data or trial data available in the source material.
Key Findings
- The Supreme Court ruled in favor of Bayer, blocking state-level lawsuits related to glyphosate.
- The ruling is based on federal regulations that found a cancer link to glyphosate unlikely.
- Bayer had previously set aside $16 billion to settle glyphosate-related lawsuits.
- Bayer has removed glyphosate from Roundup products in the U.S.
Clinical Implications
The Supreme Court's decision may limit the ability of individuals to seek legal recourse for alleged health risks associated with glyphosate.
Conclusion
The ruling represents a significant legal victory for Bayer.
Related Resources & Content
- Stat News, Source, 2026 -- Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkiller
- The ASCO Post — College of American Pathologists Issues Statement on Supreme Court Gene Patent Decision
- The ASCO Post — SCOTUS Ruling Upends Country’s Regulatory Framework, Threatens to Complicate and Delay Health-Care Delivery
- Archives of Toxicology — An Analysis of Glyphosate Toxicity and Carcinogenic Potential: Comparing the European Union's Evaluation with IARC Findings
- IARC Monograph on Glyphosate – IARC
- Glyphosate | US EPA
- Glyphosate: no critical areas of concern; data gaps identified | EFSA
- All news - ECHA
- Implementing regulation - EU - 2023/2660 - EN - EUR-Lex
- JOINT FAO/WHO MEETING ON PESTICIDE RESIDUES
- Toxicological Profile for Glyphosate - Draft for Public Comment
- Glyphosate
- Glyphosate Use and Cancer Incidence in the Agricultural Health Study | JNCI: Journal of the National Cancer Institute | Oxford Academic
- Exposure to Glyphosate-Based Herbicides and Risk for Non-Hodgkin Lymphoma: A Meta-Analysis and Supporting Evidence - PMC
- Exposure to glyphosate and risk of non-hodgkin lymphoma: an updated meta-analysis - PMC
- A systematic review and meta-analysis of glyphosate-based herbicide exposure and risk of non-Hodgkin’s lymphoma | medRxiv
- An Update of Evidence that the Herbicide Glyphosate (Roundup) is a Cause of Non-Hodgkin Lymphoma - ScienceDirect
- Cancer Prevention Overview (PDQ®) - NCI
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.